Followers | 195 |
Posts | 11477 |
Boards Moderated | 2 |
Alias Born | 06/20/2022 |
Wednesday, January 04, 2023 9:10:41 AM
Recent VVOS News
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/24/2024 06:59:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 12:05:23 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/20/2024 12:00:29 PM
- Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 09/19/2024 11:00:00 AM
- Healthcare Shares Pop On FDA Clearance • AllPennyStocks.com • 09/18/2024 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 12:00:16 PM
- Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring • GlobeNewswire Inc. • 09/18/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 08:05:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 09:00:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:24:05 PM
- Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 08/14/2024 08:05:00 PM
- Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call • GlobeNewswire Inc. • 08/14/2024 11:30:00 AM
- Form 424B1 - Prospectus [Rule 424(b)(1)] • Edgar (US Regulatory) • 08/08/2024 09:19:13 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/08/2024 04:15:19 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/30/2024 10:17:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 12:00:30 PM
- Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model • GlobeNewswire Inc. • 06/27/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:15:35 PM
- Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance • GlobeNewswire Inc. • 06/12/2024 11:30:00 AM
- Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote “FOR” Re-Election of Its Highly Qualified Directors • GlobeNewswire Inc. • 05/20/2024 05:04:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:43:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 06:54:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:16:08 PM
- Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 05/14/2024 08:05:00 PM
- Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM